By Josh White
Date: Monday 30 Sep 2024
(Sharecast News) - Celadon Pharmaceuticals announced on Monday that Jonathan Turner, its chief financial officer, was stepping down.
By Josh White
Date: Wednesday 11 Sep 2024
(Sharecast News) - Celadon Pharmaceuticals announced a strategic collaboration with Danish pharmaceutical company Valeos Pharma on Wednesday, to accelerate the production and supply of high-THC medical cannabis across Europe.
By Josh White
Date: Friday 23 Aug 2024
(Sharecast News) - Cannabis-based medicines specialist Celadon Pharmaceuticals updated the market on its financial position on Friday, amid ongoing challenges related to delays in expected funding.
Currency | UK Pounds |
Share Price | 13.75p |
Change Today | -1.75p |
% Change | -11.29 % |
52 Week High | 125.00p |
52 Week Low | 12.06p |
Volume | 332,250 |
Shares Issued | 68.85m |
Market Cap | £9.47m |
Beta | 0.11 |
RiskGrade | 111 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:06 | 183 @ 15.00p |
16:06 | 66 @ 15.00p |
16:06 | 25,000 @ 12.15p |
15:36 | 67 @ 15.00p |
15:18 | 3,365 @ 12.15p |
CEO | James Short |
CFO | Jonathan Turner |
You are here: research